OpenAI says GPT-Rosalind is out of research preview for eligible organizations worldwide
OpenAI says eligible organizations can access the life sciences reasoning model through its API, Codex and ChatGPT Enterprise, with access covering new GPT-Rosalind models as they’re released.
TLDR
OpenAI announced on September 11 that GPT-Rosalind was out of research preview for eligible organizations worldwide. The company describes it as a reasoning model built to support biology, drug discovery and translational medicine, including evidence synthesis, hypothesis generation and experimental planning. OpenAI also says Life Sciences plugins in Codex support genomic, protein structure and translational research workflows, from sourcing biological evidence to generating quality-control reports and interactive notebooks.
Combined views
—
1 Source, first seen ago
